﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Biotech Values</title><link>http://investorshub.advfn.com~/Biotech-Values-1418/</link><atom:link href="http://investorshub.advfn.com~/Biotech-Values-1418/" rel="self" type="application/rss+xml" /><description><![CDATA[Biotech Values() Board]]></description><copyright>Copyright Investorshub.com</copyright><ttl>10</ttl><item><title><![CDATA[biomaven0: recommendations for vitamins and supplements]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88185770</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88185770</guid><description><![CDATA[biomaven0]]></description><pubDate>Wed, 22 May 2013 14:47:10 GMT</pubDate></item><item><title><![CDATA[dav1234: Rigel Pharmaceuticals ($RIGL +0.4%) says it's made clinical]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88185302</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88185302</guid><description><![CDATA[dav1234]]></description><pubDate>Wed, 22 May 2013 14:40:52 GMT</pubDate></item><item><title><![CDATA[dav1234: NPS Pharmaceuticals ($NPSP +9.1%) ramps higher after pricing]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88184663</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88184663</guid><description><![CDATA[dav1234]]></description><pubDate>Wed, 22 May 2013 14:32:58 GMT</pubDate></item><item><title><![CDATA[masterlongevity: I am one who never thought Elyea would]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88184492</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88184492</guid><description><![CDATA[masterlongevity]]></description><pubDate>Wed, 22 May 2013 14:30:47 GMT</pubDate></item><item><title><![CDATA[pcrutch: I'll admit my comment was a bit like]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88182675</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88182675</guid><description><![CDATA[pcrutch]]></description><pubDate>Wed, 22 May 2013 14:08:20 GMT</pubDate></item><item><title><![CDATA[dav1234: IBio ($IBIO +23.7%) soars after saying its platform]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88181500</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88181500</guid><description><![CDATA[dav1234]]></description><pubDate>Wed, 22 May 2013 13:54:24 GMT</pubDate></item><item><title><![CDATA[sayuncle: I will be watching this on Level 2]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88178875</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88178875</guid><description><![CDATA[sayuncle]]></description><pubDate>Wed, 22 May 2013 13:21:57 GMT</pubDate></item><item><title><![CDATA[DewDiligence: Record date not set yet—will be spelled out]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88178427</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88178427</guid><description><![CDATA[DewDiligence]]></description><pubDate>Wed, 22 May 2013 13:14:30 GMT</pubDate></item><item><title><![CDATA[dav1234: i assume any $PFE buyers in early June]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88178168</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88178168</guid><description><![CDATA[dav1234]]></description><pubDate>Wed, 22 May 2013 13:10:30 GMT</pubDate></item><item><title><![CDATA[DewDiligence: $PFE’s PR on the optional$ ZTS share swap:]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88177990</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88177990</guid><description><![CDATA[DewDiligence]]></description><pubDate>Wed, 22 May 2013 13:07:40 GMT</pubDate></item><item><title><![CDATA[DewDiligence: PTLA IPOs at $14.50/share (the midpoint of anticipated range):]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88177642</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88177642</guid><description><![CDATA[DewDiligence]]></description><pubDate>Wed, 22 May 2013 13:01:52 GMT</pubDate></item><item><title><![CDATA[iwfal: $ARQL and$ GERN - Non-realtime assays:]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88177191</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88177191</guid><description><![CDATA[iwfal]]></description><pubDate>Wed, 22 May 2013 12:54:32 GMT</pubDate></item><item><title><![CDATA[apljack: $NXTM: The behavior of this stock continues to]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88176466</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88176466</guid><description><![CDATA[apljack]]></description><pubDate>Wed, 22 May 2013 12:37:09 GMT</pubDate></item><item><title><![CDATA[CynicalTrader: This is the best reference I've seen on]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88176041</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88176041</guid><description><![CDATA[CynicalTrader]]></description><pubDate>Wed, 22 May 2013 12:24:25 GMT</pubDate></item><item><title><![CDATA[dav1234: Pfizer ($PFE) plans to spin off its remaining]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88176037</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88176037</guid><description><![CDATA[dav1234]]></description><pubDate>Wed, 22 May 2013 12:24:20 GMT</pubDate></item><item><title><![CDATA[iwfal: $ARQL - what is a "non-realtime assay?]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174921</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174921</guid><description><![CDATA[iwfal]]></description><pubDate>Wed, 22 May 2013 11:50:31 GMT</pubDate></item><item><title><![CDATA[ariadndndough : Immune system cancer drugs tipped to be a]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174876</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174876</guid><description><![CDATA[ariadndndough ]]></description><pubDate>Wed, 22 May 2013 11:48:18 GMT</pubDate></item><item><title><![CDATA[Malyshek: About recommendations for vitamins and supplements:  I]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174171</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174171</guid><description><![CDATA[Malyshek]]></description><pubDate>Wed, 22 May 2013 11:04:42 GMT</pubDate></item><item><title><![CDATA[dav1234: Amarin Announces Notification of Patent Allowance for U.S.]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174169</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174169</guid><description><![CDATA[dav1234]]></description><pubDate>Wed, 22 May 2013 11:04:37 GMT</pubDate></item><item><title><![CDATA[biotech jim: Here is one of the past posts bashing]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174117</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88174117</guid><description><![CDATA[biotech jim]]></description><pubDate>Wed, 22 May 2013 11:01:15 GMT</pubDate></item><item><title><![CDATA[bladerunner1717: re: $ARQL]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88170771</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88170771</guid><description><![CDATA[bladerunner1717]]></description><pubDate>Wed, 22 May 2013 06:27:21 GMT</pubDate></item><item><title><![CDATA[WID: NPS Pharmaceuticals Prices Public Offering of Common Stock]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88169805</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88169805</guid><description><![CDATA[WID]]></description><pubDate>Wed, 22 May 2013 05:10:23 GMT</pubDate></item><item><title><![CDATA[mcbio: $ARQL people were puzzled why MetMab was a]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88169270</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88169270</guid><description><![CDATA[mcbio]]></description><pubDate>Wed, 22 May 2013 04:37:59 GMT</pubDate></item><item><title><![CDATA[caravon: $ARQL people were puzzled why MetMab was a]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88169200</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88169200</guid><description><![CDATA[caravon]]></description><pubDate>Wed, 22 May 2013 04:33:35 GMT</pubDate></item><item><title><![CDATA[iwfal: $ARQL -  Given that the hi-MET group]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88168109</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88168109</guid><description><![CDATA[iwfal]]></description><pubDate>Wed, 22 May 2013 03:33:51 GMT</pubDate></item><item><title><![CDATA[mcbio: $ARQLOne more thing. I asked$ CMO whether a]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88168104</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88168104</guid><description><![CDATA[mcbio]]></description><pubDate>Wed, 22 May 2013 03:33:33 GMT</pubDate></item><item><title><![CDATA[caravon: $ARQL AM,]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167931</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167931</guid><description><![CDATA[caravon]]></description><pubDate>Wed, 22 May 2013 03:22:09 GMT</pubDate></item><item><title><![CDATA[jq1234: I am optimistic based on ph2 trial. It]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167848</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167848</guid><description><![CDATA[jq1234]]></description><pubDate>Wed, 22 May 2013 03:17:27 GMT</pubDate></item><item><title><![CDATA[caravon: mcbio,

"Set. 2913"]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167084</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167084</guid><description><![CDATA[caravon]]></description><pubDate>Wed, 22 May 2013 02:36:00 GMT</pubDate></item><item><title><![CDATA[bladerunner1717: re: $ARQL]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167079</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167079</guid><description><![CDATA[bladerunner1717]]></description><pubDate>Wed, 22 May 2013 02:35:46 GMT</pubDate></item><item><title><![CDATA[jq1234: If they were first mover, sure. They aren't]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167008</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88167008</guid><description><![CDATA[jq1234]]></description><pubDate>Wed, 22 May 2013 02:33:09 GMT</pubDate></item><item><title><![CDATA[bladerunner1717: jq1234,

It seems to my  uneducated eye that]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166771</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166771</guid><description><![CDATA[bladerunner1717]]></description><pubDate>Wed, 22 May 2013 02:21:42 GMT</pubDate></item><item><title><![CDATA[bladerunner1717: re: $ARQL]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166691</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166691</guid><description><![CDATA[bladerunner1717]]></description><pubDate>Wed, 22 May 2013 02:17:46 GMT</pubDate></item><item><title><![CDATA[jq1234: Almost everyone here blasted them for rushing Marquee]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166572</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166572</guid><description><![CDATA[jq1234]]></description><pubDate>Wed, 22 May 2013 02:12:17 GMT</pubDate></item><item><title><![CDATA[iwfal: $ARQL - Why don't they meet with the]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166450</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166450</guid><description><![CDATA[iwfal]]></description><pubDate>Wed, 22 May 2013 02:06:04 GMT</pubDate></item><item><title><![CDATA[jbog: Biogen and Vertex has been my favorite bio's]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166425</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166425</guid><description><![CDATA[jbog]]></description><pubDate>Wed, 22 May 2013 02:04:44 GMT</pubDate></item><item><title><![CDATA[pcrutch: You'll have to let me know when I]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166185</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88166185</guid><description><![CDATA[pcrutch]]></description><pubDate>Wed, 22 May 2013 01:53:24 GMT</pubDate></item><item><title><![CDATA[bladerunner1717: re: $ARQL]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165384</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165384</guid><description><![CDATA[bladerunner1717]]></description><pubDate>Wed, 22 May 2013 01:21:36 GMT</pubDate></item><item><title><![CDATA[DewDiligence: $BMY’s presentation at the UBS conference today was]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165379</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165379</guid><description><![CDATA[DewDiligence]]></description><pubDate>Wed, 22 May 2013 01:21:22 GMT</pubDate></item><item><title><![CDATA[mcbio: SRPTThis is type of so called binary event]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165228</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165228</guid><description><![CDATA[mcbio]]></description><pubDate>Wed, 22 May 2013 01:15:30 GMT</pubDate></item><item><title><![CDATA[jq1234: That's from someone who doesn't have a position.]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165174</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165174</guid><description><![CDATA[jq1234]]></description><pubDate>Wed, 22 May 2013 01:13:21 GMT</pubDate></item><item><title><![CDATA[DewDiligence: I used to think ADHD would’ve been a]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165073</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88165073</guid><description><![CDATA[DewDiligence]]></description><pubDate>Wed, 22 May 2013 01:09:08 GMT</pubDate></item><item><title><![CDATA[mcbio: $SRPTAA is much less relevant to me now.But,]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164963</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164963</guid><description><![CDATA[mcbio]]></description><pubDate>Wed, 22 May 2013 01:04:39 GMT</pubDate></item><item><title><![CDATA[jq1234: Terrible ticker selection, similar to old STD but]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164953</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164953</guid><description><![CDATA[jq1234]]></description><pubDate>Wed, 22 May 2013 01:04:21 GMT</pubDate></item><item><title><![CDATA[mcbio: $ARQL- Marquee trial results (as they keep coming)]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164834</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164834</guid><description><![CDATA[mcbio]]></description><pubDate>Wed, 22 May 2013 00:58:43 GMT</pubDate></item><item><title><![CDATA[DewDiligence: ADHD is not only a medical condition, but]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164826</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164826</guid><description><![CDATA[DewDiligence]]></description><pubDate>Wed, 22 May 2013 00:58:29 GMT</pubDate></item><item><title><![CDATA[jq1234: I come back to why these other treatments/indications]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164667</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164667</guid><description><![CDATA[jq1234]]></description><pubDate>Wed, 22 May 2013 00:51:37 GMT</pubDate></item><item><title><![CDATA[caravon: $ARQL Annual Meeting, 5/20/2013]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164144</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88164144</guid><description><![CDATA[caravon]]></description><pubDate>Wed, 22 May 2013 00:26:08 GMT</pubDate></item><item><title><![CDATA[ghmm: $SRPT et. al.]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88163135</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88163135</guid><description><![CDATA[ghmm]]></description><pubDate>Tue, 21 May 2013 23:36:27 GMT</pubDate></item><item><title><![CDATA[jq1234: $REGN has produced some quite good ph2 safety]]></title><link>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88162103</link><guid>http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88162103</guid><description><![CDATA[jq1234]]></description><pubDate>Tue, 21 May 2013 22:45:42 GMT</pubDate></item></channel></rss>